Clene (CLNN) major holder sells 24,925 shares at $4.81

Rhea-AI Filing Summary

Clene Inc. insider filing shows an indirect share sale by a large holder. On April 2, 2026, SymBiosis II, LLC, an entity associated with ten percent owner Ugwumba Chidozie, completed an open-market sale of 24,925 shares of Clene common stock at $4.81 per share. Following this transaction, the entity continued to hold 401,891 shares of common stock indirectly, indicating the sale represented only a portion of its overall position.

Insider Trade Summary

Net Seller: 24,925 shares ($119,889)

Net Sell 1 txn

Insider Ugwumba Chidozie

Role 10% Owner

Sold 24,925 shs ($120K)

Type	Security	Shares	Price	Value
Sale	Common Stock	24,925	$4.81	$120K

Holdings After Transaction: Common Stock — 401,891 shares (Indirect, By SymBiosis II, LLC)

Footnotes (1)

Key Figures

Shares sold: 24,925 shares Sale price per share: $4.81 per share Shares held after sale: 401,891 shares +1 more

4 metrics

Shares sold 24,925 shares Open-market sale of Clene common stock on April 2, 2026

Sale price per share $4.81 per share Reported transaction price for the April 2, 2026 sale

Shares held after sale 401,891 shares Indirect holdings through SymBiosis II, LLC following the transaction

Net shares sold 24,925 shares Net change in position from this Form 4, classified as net-sell

Key Terms

open-market sale, ten percent owner, indirect ownership

3 terms

open-market sale financial

"transaction_action: "open-market sale" for the common stock transaction"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

ten percent owner financial

"reporting person Ugwumba Chidozie is marked as "is_ten_percent_owner": 1"

indirect ownership financial

"direct_or_indirect: "I" with nature_of_ownership: "By SymBiosis II, LLC""

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ugwumba Chidozie

(Last) (First) (Middle)

609 SW 8TH STREET

SUITE 510

(Street)

BENTONVILLE ARKANSAS 72712

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Clene Inc. [ CLNN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/02/2026		S		24,925	D	$4.81	401,891	I	By SymBiosis II, LLC

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Chidozie Ugwumba	04/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Clene (CLNN) report in this Form 4?

Clene reported an indirect open-market sale of 24,925 shares of common stock. The sale was executed on April 2, 2026 by SymBiosis II, LLC, an entity associated with ten percent owner Ugwumba Chidozie, at a reported price of $4.81 per share.

Who executed the Clene (CLNN) share sale disclosed in this filing?

The sale was executed by SymBiosis II, LLC, identified as holding the shares indirectly for reporting person Ugwumba Chidozie. The filing shows Chidozie as a ten percent owner of Clene Inc., with the shares reported under indirect ownership through the LLC entity.

How many Clene (CLNN) shares were sold and at what price?

The filing shows an open-market sale of 24,925 shares of Clene common stock at a price of $4.81 per share. This single transaction is coded as a sale and classified as a non-derivative transaction in common stock.

How many Clene (CLNN) shares does the reporting holder own after the sale?

After the reported sale, the filing lists 401,891 shares of Clene common stock as indirectly owned. These shares are held through SymBiosis II, LLC, which is noted in the Form 4 as the nature of ownership for reporting person Ugwumba Chidozie.

Is this Clene (CLNN) insider trade an open-market sale or another type of transaction?

The transaction is characterized as an open-market sale of common stock. The Form 4 uses transaction code “S” and describes it as a sale in an open market or private transaction, indicating a straightforward disposition rather than an option exercise or gift.